Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2003-2-13
pubmed:abstractText
The safety and efficacy of a 1% cream formulation of pimecrolimus, a selective, nonsteroid immunomodulator, was studied in infants with atopic dermatitis (AD).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0022-3476
pubmed:author
pubmed:issnType
Print
pubmed:volume
142
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
155-62
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12584537-Administration, Cutaneous, pubmed-meshheading:12584537-Analysis of Variance, pubmed-meshheading:12584537-Anti-Inflammatory Agents, Non-Steroidal, pubmed-meshheading:12584537-Dermatitis, Atopic, pubmed-meshheading:12584537-Dermatologic Agents, pubmed-meshheading:12584537-Diarrhea, pubmed-meshheading:12584537-Double-Blind Method, pubmed-meshheading:12584537-Female, pubmed-meshheading:12584537-Fever, pubmed-meshheading:12584537-Humans, pubmed-meshheading:12584537-Infant, pubmed-meshheading:12584537-Male, pubmed-meshheading:12584537-Ointments, pubmed-meshheading:12584537-Pharyngitis, pubmed-meshheading:12584537-Respiratory Tract Infections, pubmed-meshheading:12584537-Safety, pubmed-meshheading:12584537-Severity of Illness Index, pubmed-meshheading:12584537-Tacrolimus, pubmed-meshheading:12584537-Time Factors, pubmed-meshheading:12584537-Treatment Outcome
pubmed:year
2003
pubmed:articleTitle
Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants.
pubmed:affiliation
Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study